Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2006 1
2007 1
2008 2
2009 4
2010 7
2011 6
2012 8
2013 7
2014 5
2015 8
2016 9
2017 8
2018 3
2019 5
2020 6
2021 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity.
Rosenberg EC, Chamberland S, Bazelot M, Nebet ER, Wang X, McKenzie S, Jain S, Greenhill S, Wilson M, Marley N, Salah A, Bailey S, Patra PH, Rose R, Chenouard N, Sun SED, Jones D, Buzsáki G, Devinsky O, Woodhall G, Scharfman HE, Whalley BJ, Tsien RW. Rosenberg EC, et al. Among authors: whalley bj. Neuron. 2023 Apr 19;111(8):1282-1300.e8. doi: 10.1016/j.neuron.2023.01.018. Epub 2023 Feb 13. Neuron. 2023. PMID: 36787750 Free article.
Cannabinoid treatments in epilepsy and seizure disorders.
Devinsky O, Jones NA, Cunningham MO, Jayasekera BAP, Devore S, Whalley BJ. Devinsky O, et al. Among authors: whalley bj. Physiol Rev. 2024 Apr 1;104(2):591-649. doi: 10.1152/physrev.00049.2021. Epub 2023 Oct 26. Physiol Rev. 2024. PMID: 37882730 Review.
Cannabinoids and Epilepsy.
Rosenberg EC, Tsien RW, Whalley BJ, Devinsky O. Rosenberg EC, et al. Among authors: whalley bj. Neurotherapeutics. 2015 Oct;12(4):747-68. doi: 10.1007/s13311-015-0375-5. Neurotherapeutics. 2015. PMID: 26282273 Free PMC article. Review.
Molecular Pharmacology of Phytocannabinoids.
Turner SE, Williams CM, Iversen L, Whalley BJ. Turner SE, et al. Among authors: whalley bj. Prog Chem Org Nat Prod. 2017;103:61-101. doi: 10.1007/978-3-319-45541-9_3. Prog Chem Org Nat Prod. 2017. PMID: 28120231 Review.
Cannabinoids in the Treatment of Neurological Disorders.
Devinsky O, Whalley BJ, Di Marzo V. Devinsky O, et al. Among authors: whalley bj. Neurotherapeutics. 2015 Oct;12(4):689-91. doi: 10.1007/s13311-015-0388-0. Neurotherapeutics. 2015. PMID: 26334724 Free PMC article. No abstract available.
Species-specific susceptibility to cannabis-induced convulsions.
Whalley BJ, Lin H, Bell L, Hill T, Patel A, Gray RA, Elizabeth Roberts C, Devinsky O, Bazelot M, Williams CM, Stephens GJ. Whalley BJ, et al. Br J Pharmacol. 2019 May;176(10):1506-1523. doi: 10.1111/bph.14165. Epub 2018 Mar 25. Br J Pharmacol. 2019. PMID: 29457829 Free PMC article.
Anabolic androgenic steroid abuse in the United Kingdom: An update.
Mullen C, Whalley BJ, Schifano F, Baker JS. Mullen C, et al. Among authors: whalley bj. Br J Pharmacol. 2020 May;177(10):2180-2198. doi: 10.1111/bph.14995. Epub 2020 Mar 3. Br J Pharmacol. 2020. PMID: 31989581 Free PMC article. Review.
Molecular Targets of Cannabidiol in Neurological Disorders.
Ibeas Bih C, Chen T, Nunn AV, Bazelot M, Dallas M, Whalley BJ. Ibeas Bih C, et al. Among authors: whalley bj. Neurotherapeutics. 2015 Oct;12(4):699-730. doi: 10.1007/s13311-015-0377-3. Neurotherapeutics. 2015. PMID: 26264914 Free PMC article. Review.
72 results